FGF2‐induced downstream signaling mediated via FGFR1 has been shown to induce glioblastoma radioresistance through its downstream effector PLCγ,36 indicative a potential role of FGFR1 in modulating normal cell radiosensitivity. The gene discussed is FGF2; the disease is glioblastoma.